UnitedHealth Group has experienced a remarkable turnaround in 2026 following a challenging year in 2025, largely attributed to the integration of artificial intelligence (AI) into its operations.
As the largest health insurer in the United States, enrolling around 45 million members, UnitedHealth grapples with the complexities of managing substantial amounts of data related to benefits, claims, cost estimates, provider options, prescriptions, and wellness plans. The company also leads the market in Medicare Advantage, holding a dominant position in 41% of U.S. counties.
This vast reach underscores the potential for AI to enhance efficiency within the health insurance sector. In March, UnitedHealth unveiled Avery, a generative AI chatbot designed to facilitate the healthcare experience for its members by learning from their interactions. Avery assists members by providing insights into their benefits and claims status, delivering cost estimates, finding healthcare providers, scheduling appointments, and managing ID cards and drug benefits.
Currently, Avery is operational for 6.5 million members enrolled in employer-sponsored plans under UnitedHealthcare and another 160,000 members within UnitedHealthcare's Medicare Advantage offerings. By the year’s end, the company plans to extend Avery's capabilities to over 20 million members.
Avery is just one of the more than 1,000 AI applications being implemented across UnitedHealth’s insurance, health delivery, and pharmacy divisions. The company has committed an additional $1.6 billion to artificial intelligence initiatives this year, aiming to enhance care delivery and minimize administrative inefficiencies.
Investors have responded positively to UnitedHealth's strategic use of AI. The company's stock has surged approximately 53% since the introduction of the Avery system in late March. This uptrend coincided with robust first-quarter earnings that surpassed market expectations, prompting UnitedHealth to raise its earnings forecast for 2026 to $18.25 per share, up from $17.75.
Moreover, closely tied to the company’s AI advancements, UnitedHealth reported a reduction in its medical benefit ratio—defined as the portion of revenue allocated to healthcare costs—down to 83.9%, improved from last year’s 84.8% and significantly beneath the 85.5% anticipated by analysts.
In early April, further positive news emerged with the announcement from the Trump administration regarding a 2.48% increase in Medicare Advantage payments for 2027, amounting to approximately $13 billion—considerably exceeding the initial projection of a mere 0.09%.
This reversal of fortune marks a stark contrast to recent history. In December 2024, the firm mourned the loss of its CEO, Brian Thompson, due to a tragic event in New York City. The following year was tumultuous as the company faced civil and criminal investigations by the Justice Department related to its billing practices, contributing to a sharp stock decline of 60% from early April to late July 2025.
However, over the last couple of months, UnitedHealth's share price has rebounded significantly. Should the company continue leveraging AI to optimize its extensive health insurance operations, there are promising prospects for further growth in the upcoming months.
